GURU.Markets stock price, segment price, and overall market index valuation
The company's share price PTHL
Pheton's value as a pharmaceutical holding company is determined by the value of its assets and the success of its investment strategy. The potential share price will depend on the management team's ability to create value and adapt to market conditions.
Share prices of companies in the market segment - Pharma other
Pono Capital Three is a SPAC in the process of merging with Meili Beauty, a beauty tech company. We've categorized it as "Other Pharma" because it's related to health and personal care. The chart below shows how investors value similar public shell companies.
Broad Market Index - GURU.Markets
Pheton is a holding company focused on the development and commercialization of pharmaceutical products. As a participant in this sector, it is included in our GURU.Markets index. The chart below reflects the overall stock market performance. Compare it with the company's stock price to assess the industry's prospects.
Change in the price of a company, segment, and market as a whole per day
PTHL - Daily change in the company's share price PTHL
Pheton Holdings Ltd's daily price change reflects volatility in the pharmaceutical sector. This indicator measures its sensitivity to demand for its products and competition in Asian markets, serving as a valuable analytical tool.
Daily change in the price of a set of shares in a market segment - Pharma other
The pharmaceutical sector in which Pheton Holdings Ltd operates is highly dynamic. This chart reflects the average volatility of the industry. It serves as a benchmark for assessing Pheton's sensitivity to general trends, pricing policies, and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
Pheton Holdings is a pharmaceutical company developing new drugs. Its shares, like many in the sector, are volatile and react to news about clinical trials. These scientifically driven movements are part of the overall stock market landscape.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization PTHL
Pheton Holdings Ltd's year-over-year performance tells the story of its role in the pharmaceutical market. Its 12-month market cap reflects its ability to effectively manage its supply chain, distribution, and adapt to the complex and regulated Chinese healthcare environment, which is key to its success.
Annual dynamics of market capitalization of the market segment - Pharma other
As a private holding company, Pheton likely has a diversified pharmaceutical investment portfolio. Its growth dynamics depend on the success of its portfolio companies. Compared to the sector, its flexibility could allow it to grow at a faster pace.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pheton Holdings, a Chinese pharmaceutical company, reflects the unique dynamics of China's healthcare system. Its performance depends on the inclusion of drugs in government regulations, pricing policies, and competition in a vast but strictly regulated market, creating a unique trajectory that differs from that of global pharmaceutical giants.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization PTHL
Pheton Holdings is a pharmaceutical company. Its monthly performance is typical for the sector: it depends on progress in its scientific developments and clinical programs. News of trial results or funding raises are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Pharma other
Pheton Holdings is a Chinese pharmaceutical company. Its success depends on the regulatory environment, competition, and demand for drugs in the vast Chinese market. The chart below shows the overall dynamics of the pharmaceutical sector, but with an adjustment for the specifics of operating in China.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Pheton Holdings is a Chinese pharmaceutical company. Its business and stock are entirely dependent on China's healthcare system, regulation, and competition in its domestic market. The company's performance is uncorrelated with global market trends and reflects the unique characteristics of China's pharmaceutical sector.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization PTHL
Pheton Holdings, according to data, is a pharmaceutical company. Weekly stock performance in this sector, especially for smaller companies, depends entirely on drug development progress and regulatory decisions.
Weekly dynamics of market capitalization of the market segment - Pharma other
Pheton Holdings is a pharmaceutical company focused on the Chinese market. This chart allows us to assess how the company's shares react to local regulatory news and healthcare trends compared to the global pharmaceutical sector. How sensitive is it to regional specifics?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Pheton Holdings is a pharmaceutical company whose shares follow the rhythm of news about clinical trials and drug approvals. The chart clearly shows how its weekly performance is detached from the broader market, moving along its own unique trajectory.
Market capitalization of the company, segment and market as a whole
PTHL - Market capitalization of the company PTHL
The data on Pheton Holdings (PTHL) may be inaccurate. The chart of such a pharmaceutical company, if it exists, would reflect the state and regulatory environment of China's traditional medicine or generics sector, and its market cap would be sensitive to local healthcare trends.
PTHL - Share of the company's market capitalization PTHL within the market segment - Pharma other
Pheton Holdings is a pharmaceutical company focused on a specific market segment. Its share of the overall market capitalization of the pharmaceutical sector reflects its niche position. The company's market capitalization is an indicator of the commercial success of its products or, if it is in the development stage, the confidence of investors in its scientific research and future drugs.
Market capitalization of the market segment - Pharma other
Pheton Holdings is likely a pharmaceutical company. What is the size of this entire industry? The chart below shows the total market capitalization of this sector. Its growth reflects humanity's constant need for new drugs, and its dynamics reflect the successes and failures of clinical trials.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Pheton Holdings chart reflects the state of the pharmaceutical market through the lens of a distributor and manufacturer. Its market capitalization is an indicator of drug sales volumes and the company's ability to manage its supply chain. This diagram illustrates the functioning of the pharmaceutical industry's "circulatory system."
Book value capitalization of the company, segment and market as a whole
PTHL - Book value capitalization of the company PTHL
Pheton Holdings's assets are its production lines and assembly plants, where various pharmaceutical and medical products are created. Book value reflects the true value of these production assets. The chart below shows how the value of this industrial foundation has changed.
PTHL - Share of the company's book capitalization PTHL within the market segment - Pharma other
Pheton Holdings Ltd is a pharmaceutical company whose strength lies in its manufacturing facilities and R&D centers. These factories and laboratories form the physical foundation for the development and commercialization of its products in China. The chart shows the company's control over this pharmaceutical infrastructure in its region and segment.
Market segment balance sheet capitalization - Pharma other
Pheton Holdings is likely a pharmaceutical or biotech company. This sector, as the chart shows, is capital-intensive. Its business requires investment in laboratories and, if successful, in manufacturing facilities to create its drugs.
Book value of all companies included in the broad market index - GURU.Markets
Pheton Holdings' assets include production facilities and a distribution network for pharmaceutical and healthcare products in China. Its book value reflects the industrial and commercial scale of this player in the domestic Chinese healthcare market.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - PTHL
Pheton Holdings is a holding company with assets in the pharmaceutical industry. Its market valuation is the sum of its parts, which the market may value at a discount. The chart shows how investors view its portfolio and management's ability to create value.
Market to book capitalization ratio in a market segment - Pharma other
Pheton Holdings is a holding company operating in the pharmaceutical sector. This chart shows how the market values its assets and subsidiaries, as well as its development strategy, by comparing total market capitalization to total book value.
Market to book capitalization ratio for the market as a whole
Pheton Holdings is a pharmaceutical company. Its valuation depends on its drug portfolio and the stage of their development. Patents and clinical trial data are its core assets. This chart illustrates how much the intellectual property premium in the pharmaceutical industry exceeds the average market valuation.
Debts of the company, segment and market as a whole
PTHL - Company debts PTHL
Pheton Holdings is likely a pharmaceutical company or holding company. In this industry, capital is vital for funding research, clinical trials, manufacturing, or acquiring rights to new drugs. This chart reflects the company's overall financial strategy for managing its assets and funding growth in the pharmaceutical sector.
Market segment debts - Pharma other
Pheton Holdings is a holding company operating in the pharmaceutical sector. Its financial structure reflects the combined assets and liabilities of its subsidiaries. This chart shows the consolidated balance sheet, which provides a general overview of the holding's size and financial policies.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio PTHL
Pheton Holdings is likely a pharmaceutical company. This chart shows its dependence on external financing. In pharmaceuticals, the path from development to market is long and expensive. The debt burden along this path greatly increases the risks, as failure at any stage can make it impossible to meet creditor obligations.
Market segment debt to market segment book capitalization - Pharma other
Pheton Holdings appears to operate in the pharmaceutical sector in China. This market is vast but highly competitive and heavily regulated. The chart shows the overall debt burden in the industry, providing context for assessing how the company manages its finances in this unique environment.
Debt to book value of all companies in the market
Pheton Holdings is a pharmaceutical company. Its financial needs vary greatly depending on its stage (development or sales). If it sells drugs, debt can be used for marketing. If it is in R&D, it relies on investors. This chart provides context for assessing the company's stage and its financial strategy.
P/E of the company, segment and market as a whole
P/E - PTHL
This chart shows the valuation of Pheton Holdings, a pharmaceutical company. The P/E ratio shows how investors value its drug portfolio. It reflects current sales, the competitive environment, and expectations for future products that should support the company's growth.
P/E of the market segment - Pharma other
Pheton Holdings is a pharmaceutical company engaged in the development, production, and sale of a wide range of medications. This chart shows the average valuation for the sector, which helps understand how the market views this company's portfolio and strategy.
P/E of the market as a whole
Pheton Holdings is a holding company operating in the pharmaceutical industry. The valuation of diversified holdings is often the sum of the values of their diverse assets. The company's performance depends on success in its specific niches, rather than on general market trends, as illustrated by this chart, which can both smooth out volatility and complicate analysis.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company PTHL
Pheton Holdings is a Chinese pharmaceutical company specializing in the production and sale of traditional Chinese and chemical medicines. This chart reflects analyst expectations for the state of the healthcare system and pharmaceutical market in China. Future profitability depends on sales volumes of its products and regulatory policies.
%20P%2FE%20PTHL&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-PTHL&v=1772530721475 "Chart of the company's future (projected) P/E PTHL")
Future (projected) P/E of the market segment - Pharma other
Pheton Holdings is a pharmaceutical company. Its valuation relative to other players in the pharmaceutical industry reflects investor opinions on its product portfolio, whether generic or branded, and its market position. It also reflects how the market views its growth strategy and future profitability.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772530721586 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Pheton Holdings is likely a pharmaceutical company or holding company operating in the Chinese market. Its success depends on its product portfolio, regulatory environment, and healthcare system in China. This chart reflects global investor sentiment, which influences the valuation of Chinese stocks traded on country-specific risk.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772530721649 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit PTHL
Pheton Holdings is a Chinese pharmaceutical company. Its financial results, illustrated by this chart, depend on the production and sales of its portfolio of drugs in the Chinese domestic market. Competition and government price regulation are important factors for its business.
Profit of companies in the market segment - Pharma other
Pheton Holdings is engaged in the pharmaceutical business. This chart shows overall profitability in the pharmaceutical industry. It helps assess the common challenges faced by all market players, including smaller companies like Pheton, such as regulation, generic competition, and R&D costs.
Overall market profit
Pheton Holdings is likely a pharmaceutical company or holding company in this field. Its success will depend on its drug portfolio, its life cycle, and the competitive environment in specific therapeutic areas. The overall corporate earnings trend shown in this chart is merely a background factor for PTHL.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company PTHL
Pheton Holdings is a pharmaceutical company engaged in the development and production of medicines. Its future profit forecast depends on the success of its product portfolio and developments. This chart shows analysts' expectations for sales of its current drugs and the potential of new drugs in development.
%20profit%20of%20the%20company%20PTHL&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-PTHL&v=1772530721967 "Graph of future (projected) profit of the company PTHL")
Future (predicted) profit of companies in the market segment - Pharma other
Pheton Holdings is likely a holding company operating in the pharmaceutical sector. Such companies may own stakes in various pharmaceutical businesses, from manufacturing to distribution. This chart shows forecasts for the pharmaceutical sector. It allows one to assess how the company's diversified portfolio may relate to overall industry trends and risks.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772530722024 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
This reflects the investment climate, which is critical for pharmaceutical companies. Pheton Holdings, which operates in this sector, depends on the availability of capital for research and development. Economic growth and risk appetite facilitate financing, while a downturn makes investors more selective.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772530722150 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - PTHL
Pheton Holdings likely operates in the pharmaceutical sector. This metric for such a company demonstrates how investors assess its current or potential revenue streams, which may be related to drug sales or licensing agreements.
P/S market segment - Pharma other
Pheton Holdings is engaged in pharmaceutical activities. This chart shows the average valuation in the pharmaceutical sector. It serves as a benchmark for investors to compare how the market values Pheton's business model, product portfolio, and revenue growth potential compared to other companies in the broader pharmaceutical industry.
P/S of the market as a whole
Pheton Holdings Ltd is a pharmaceutical company specializing in the production and distribution of pharmaceuticals. The company's revenue is generated through the sale of a wide range of drugs. This chart allows you to assess how the market views the traditional pharmaceutical business model versus innovative biotech.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company PTHL
Pheton Holdings, operating in the pharmaceutical market, depends on the successful development and commercialization of its products. The company's future revenue, as expected by investors, is reflected in this chart. It shows the market's assessment of its development pipeline and its ability to compete in the healthcare sector.
%20P%2FS%20PTHL&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-PTHL&v=1772530722435 "The graph of the company's future (projected) P/S PTHL")
Future (projected) P/S of the market segment - Pharma other
Pheton Holdings is likely a pharmaceutical company or distributor operating in the Chinese market. Its success depends on its product portfolio and its ability to navigate China's complex regulatory environment. This chart compares its future revenue expectations with those of other companies in the region's pharmaceutical sector.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772530722531 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
This chart shows the overall market forecast for the pharmaceutical industry. For Pheton Holdings, a pharmaceutical company, it's a barometer of the overall stability of the healthcare system and purchasing power. Economic optimism supports demand for medications and provides a predictable business environment.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772530722554 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales PTHL
Pheton Holdings is a Chinese pharmaceutical company engaged in the production and distribution of medications. This chart shows revenue from sales of a wide range of medications in the Chinese market. Its dynamics depend on drug demand, pricing policy, and the regulatory environment in China's healthcare system.
Sales of companies in the market segment - Pharma other
Pheton Holdings is a pharmaceutical company specializing in the development and production of drugs. This chart illustrates the overall dynamics of the pharmaceutical industry. Companies like Pheton contribute to the overall market by offering both generics and, potentially, innovative products, meeting the needs of the healthcare system.
Overall market sales
Pheton Holdings Ltd. is a pharmaceutical company engaged in the development and sale of pharmaceuticals. Its revenues depend on demand within the healthcare system. This general economic activity pattern influences public and private healthcare spending, which shapes the market for the company's products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company PTHL
Pheton Holdings is a pharmaceutical company engaged in the production and sale of traditional Chinese and modern medicines in China. Its revenue depends on demand for its products within the Chinese healthcare system. This chart shows analyst forecasts for the Chinese pharmaceutical market and the company's position within it.
%20sales%20of%20the%20company%20PTHL&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-PTHL&v=1772530722833 "Schedule of future (projected) sales of the company PTHL")
Future (projected) sales of companies in the market segment - Pharma other
Pheton Holdings is a company operating in the pharmaceutical industry. This chart shows general expectations for the entire pharmaceutical sector. It helps understand general industry trends, such as R&D spending trends and regulatory changes that impact all market players, including Pheton.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772530722864 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Pheton Holdings Ltd is a pharmaceutical company engaged in the production and sale of various medications. Its business depends on the demand for medications and pricing policies within the healthcare system. This graph, reflecting the overall state of the economy, influences healthcare budgets and the population's purchasing power, which in turn drives demand for pharmaceutical products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772530723026 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality PTHL
Pheton Holdings is in the pharmaceutical business. This chart shows its ability to convert revenue into profit. The company's profitability depends on the success of its product portfolio, production efficiency, and control of marketing and distribution costs. Generic competition can be a significant pressure.
Market segment marginality - Pharma other
Pheton Holdings manufactures and sells pharmaceutical products in China. Profitability in this industry depends on the company's product portfolio, production capacity, and distribution channels. This chart shows the average profitability in the pharmaceutical sector, allowing one to assess how effectively Pheton Holdings operates in its competitive market.
Market marginality as a whole
Pheton Holdings is a holding company operating in the pharmaceutical sector. This overall market return chart serves as a general indicator of the industry's performance. However, Pheton's actual profitability depends on the success of the specific drugs and areas in which it invests, as well as the competitive environment within these specific niches.
Employees in the company, segment and market as a whole
Number of employees in the company PTHL
Pheton Holdings is a Chinese pharmaceutical distribution company. This chart shows the team of sales and logistics specialists who ensure the supply of medications to medical institutions. The number of personnel directly reflects the scale of its distribution network.
Share of the company's employees PTHL within the market segment - Pharma other
Pheton Holdings is a pharmaceutical company whose operations require a strong team for research, production, and distribution. This chart shows its importance as an employer in the pharmaceutical industry. It reflects the proportion of chemists, technologists, and sales specialists the company employs to support the entire life cycle of its products.
Number of employees in the market segment - Pharma other
Pheton Holdings operates in the pharmaceutical industry. Pharmaceuticals are one of the most science-intensive and highly regulated sectors. This graph shows that the entire chain, from research and clinical trials to production and sales, requires a huge staff of highly qualified specialists: chemists, biologists, doctors, lawyers, and marketers.
Number of employees in the market as a whole
Pheton Holdings represents the pharmaceutical industry, which requires long development cycles and major investments. Sustainable employment growth, as seen in this graph, is only possible in an economy capable of funding such long-term projects. Each new drug requires years of work by hundreds of specialists and billions of dollars in investment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company PTHL (PTHL)
Pheton Holdings (PTHL) is a Chinese pharmaceutical company. This chart reflects both capital intensity (production capacity, if any) and intellectual capital (the portfolio of approved drugs and developments). It shows the combined market valuation of these assets—the ability to produce and sell drugs—per employee.
%20of%20the%20company%20PTHL%20(PTHL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-PTHL-PTHL&v=1772530723247 "Chart of market capitalization per employee (in thousands of dollars) of the company PTHL (PTHL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Pheton Holdings is a pharmaceutical company. In this industry, success depends on research, development, and subsequent commercialization. This chart shows how the market values this entire cycle per employee. It helps understand whether the company is an efficient developer or more focused on lower-margin products.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772530723284 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Pheton Holdings Ltd is a pharmaceutical company. This chart shows the average market value generated by one specialist. It helps evaluate the company's business model in the competitive pharmaceutical industry against the backdrop of the overall economy.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772530723340 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company PTHL (PTHL)
Pheton Holdings is a Chinese pharmaceutical company. Unlike R&D startups, they likely manufacture and sell drugs. This chart shows how efficiently their factories and sales team generate profit. It reflects the margins of their product portfolio per employee.
%20Chart%20PTHL%20(PTHL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-PTHL-PTHL&v=1772530723372 "Company Profit Per Employee (in thousands of dollars) Chart PTHL (PTHL)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Pheton Holdings is a pharmaceutical company specializing in the production and distribution of traditional Chinese medicine and other pharmaceuticals. Its business model encompasses both production and marketing. This chart shows how effectively the company manages its production and distribution operations, reflecting overall profitability and employee productivity.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772530723409 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Pheton Holdings (PTHL) — (Little info, micro-cap). Likely a Chinese pharmaceutical or medtech company. This metric measures the economy-wide average profit per employee in the US. It helps investors assess how PTHL's (pharmaceutical industry in China) model compares in labor efficiency (USD generation per engineer) to the US market average.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772530723417 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee PTHL (PTHL)
Pheton Holdings is a pharmaceutical company. This chart reflects the effectiveness of its business model, whether it's manufacturing, distribution, or drug development. It shows how successfully the company operates in its market, converting its expertise and assets into a stable revenue stream.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-PTHL-PTHL&v=1772530723468 "Sales chart per company employee PTHL (PTHL)")
Sales per employee in the market segment - Pharma other
Pheton Holdings is a pharmaceutical company, likely focused on traditional Chinese medicine or generics. This chart shows the average revenue per employee in this segment. It helps assess how productive Pheton's team (production, R&D, sales) is in its specific market compared to other pharmaceutical companies.
Sales per employee for the market as a whole
Pheton Holdings — *The PTHL ticker data is unclear. Based on the name and "Pharma other" category*, this is a pharmaceutical company. This chart shows how efficiently their team (R&D, manufacturing, sales) generates revenue. If the company is a generic company, this is an indicator of production efficiency; if it is an innovative company, it is an indicator of R&D and sales efficiency.
Short shares by company, segment and market as a whole
Shares shorted by company PTHL (PTHL)
Pheton Holdings (FTRK) is a Chinese company (ADR) listed as a pharmaceutical manufacturer and distributor. It's a highly opaque "micro cap." This chart reflects investor skepticism, as investors may question the company's operations, the reliability of its financial statements, or the availability of actual products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-PTHL-PTHL&v=1772530723513 "Short Shares Chart for the Company PTHL (PTHL)")
Shares shorted by market segment - Pharma other
Pheton Holdings Ltd is a Chinese pharmaceutical company engaged in the distribution and sale of drugs on the domestic market. This indicator reflects the total volume of short positions in the pharmaceutical sector. An increase in short positions here may indicate that investors perceive risks of price pressure from government procurement in China, which affects the margins of all distributors.
Shares shorted by the overall market
Pheton Holdings is a Chinese pharmaceutical company. This chart shows the overall market pessimism. Investors are concerned about both a slowing Chinese economy and government pressure on drug prices (VBP policy). This creates a risk of declining profitability for all pharmaceutical manufacturers in the country.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator PTHL (PTHL)
This oscillator for Pheton Holdings is an indicator of volatility in the Chinese pharmaceutical industry. The company distributes and manufactures pharmaceutical products. "Overbought" levels (above 70) may be caused by rising demand or news of expansion. Lack of transparency, regulatory risks, and pricing pressure from Beijing often lead to "oversold" levels.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-PTHL-PTHL&v=1772530723620 "RSI 14 indicator chart for the company's stock PTHL (PTHL)")
RSI 14 Market Segment - Pharma other
Pheton Holdings (PTHL) is a *pharma* holding (China). The "Pharma Other" sector (pharma/China) thrives on "cycles" (and regulation). RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is PTHL's growth a niche or a general "hype"?
RSI 14 for the overall market
Pheton Holdings (PTHL) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an easy way to raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PTHL (PTHL)
Pheton Holdings is a Chinese company operating in pharmaceutical distribution and retail. This chart shows the average 12-month analyst forecast. Their target price (if any) reflects their view on competition in China's pharmaceutical retail sector and regulatory risks.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PTHL-PTHL&v=1772530723863 "A chart showing analyst consensus forecasts for the expected stock price. PTHL (PTHL)")
The difference between the consensus estimate and the actual stock price PTHL (PTHL)
Pheton Holdings is a Chinese pharmaceutical company specializing in traditional Chinese medicine (TCM) and health products. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe they can monetize this traditional market against the backdrop of modern pharma.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PTHL-PTHL&v=1772530723936 "A chart showing the difference between the consensus forecast and the actual stock price. PTHL (PTHL)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Pheton (Fangsheng) is a Chinese pharmaceutical distributor focused on supplying drugs to rural and less-developed regions of China. This chart shows analysts' overall expectations for the pharmaceutical sector. It reflects whether experts believe demand for healthcare in rural China will grow.
Analysts' consensus forecast for the overall market share price
Pheton Holdings is a Chinese holding company operating in the healthcare and pharmaceutical sectors in China. This is a "defensive" sector, as demand for medicine is stable. This chart shows the overall sentiment of the *global* market. For PTHL, which operates in China, overall optimism is important, but investors also value the stability of their "defensive" business during periods of global pessimism.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index PTHL
Pheton Holdings is likely a Chinese company operating in the healthcare or pharmaceutical sector. This chart is a summary indicator of their business model. It reflects their operational efficiency, their margins, and (critically) the enormous risks associated with transparency, the regulatory environment (NMPA), and the Chinese economy.
AKIMA Market Segment Index - Pharma other
Pheton Holdings (PTHL) is a Chinese pharmaceutical company that appears to be developing or distributing a wide range of drugs in the Chinese market. The chart shows the average index for its segment, helping investors assess how PTHL compares to the average in China's competitive pharmaceutical industry.
The AKIM Index for the overall market
Pheton Holdings is a Chinese company that develops software for brachytherapy (radiation therapy) and provides medical services. This chart, showing the average (global/US) market value, serves as a benchmark. It helps assess how PTHL, a niche MedTech player, compares to overall macroeconomic trends.
